{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:44:31Z","timestamp":1762782271480},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00104-019-0935-z","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:05:20Z","timestamp":1552565120000},"page":"548-556","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chirurgische Eingriffe bei Patienten mit systemischer Mastzellaktivierungserkrankung"],"prefix":"10.1007","volume":"90","author":[{"given":"B.","family":"Sido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Homann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-J.","family":"Hertfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Zienkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-P.","family":"Christians","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schablin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"M\u00fccke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J.","family":"Molderings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"935_CR1","doi-asserted-by":"publisher","first-page":"e76241","DOI":"10.1371\/journal.pone.0076241","volume":"8","author":"GJ Molderings","year":"2013","unstructured":"Molderings GJ, Haenisch B, Bogdanow M et\u00a0al (2013) Familial occurrence of systemic mast cell activation disease. PLoS ONE 8:e76241","journal-title":"PLoS ONE"},{"key":"935_CR2","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/ng.3696","volume":"48","author":"JJ Lyons","year":"2016","unstructured":"Lyons JJ, Yu X, Hughes JD et\u00a0al (2016) Elevated basal serum tryptase identifies a\u00a0multisystem disorder associated with increased TPSAB1 copy number. Nat Genet 48:1564\u20131569","journal-title":"Nat Genet"},{"key":"935_CR3","first-page":"171","volume":"31","author":"N Lazaridis","year":"2018","unstructured":"Lazaridis N, Germanidis G (2018) Current insights into the innate immune system dysfunction in irritable bowel syndrome. Ann Gastroenterol 31:171\u2013187","journal-title":"Ann Gastroenterol"},{"key":"935_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00104-013-2642-5","volume":"85","author":"B Sido","year":"2014","unstructured":"Sido B, Dumoulin FL, Homann J et\u00a0al (2014) Chirurgische Eingriffe an Patienten mit Mastzell\u00fcberaktivit\u00e4tserkrankung \u2013 Operationsrelevante Aspekte am Beispiel einer Cholezystektomie. Chirurg 85:327\u2013333","journal-title":"Chirurg"},{"key":"935_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1756-8722-4-10","volume":"4","author":"GJ Molderings","year":"2011","unstructured":"Molderings GJ, Brettner S, Homann J et\u00a0al (2011) Mast cell activation disease: a\u00a0concise practical guide for diagnostic workup and therapeutic options. J\u00a0Hematol Oncol 4:10","journal-title":"J Hematol Oncol"},{"key":"935_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3109\/07853890.2016.1161231","volume":"48","author":"LB Afrin","year":"2016","unstructured":"Afrin LB, Butterfield JH, Raithel M et\u00a0al (2016) Often seen, rarely recognized: mast cell activation disease\u2014a\u00a0guide to diagnosis and therapeutic options. Ann Med 48:190\u2013201","journal-title":"Ann Med"},{"issue":"174","key":"935_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.trsl.2016.01.001","volume":"16","author":"GJ Molderings","year":"2016","unstructured":"Molderings GJ (2016) Transgenerational transmission of systemic mast cell activation disease-genetic and epigenetic features. Transl Res 16(174):86\u201397","journal-title":"Transl Res"},{"key":"935_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0029-1245707","volume":"49","author":"T Frieling","year":"2011","unstructured":"Frieling T, Meis K, Kolck UW et al (2011) Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome. Z\u00a0Gastroenterol 49:191\u2013194","journal-title":"Z Gastroenterol"},{"key":"935_CR9","first-page":"2031480","volume":"2016","author":"KN Lee","year":"2016","unstructured":"Lee KN, Lee OY (2016) The role of mast cells in irritable bowel syndrome. Gastroenterol Res Pract 2016:2031480","journal-title":"Gastroenterol. Res. Pract."},{"key":"935_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5056\/jnm15137","volume":"22","author":"L Zhang","year":"2016","unstructured":"Zhang L, Song J, Hou X (2016) Mast cells and irritable bowel syndrome: from the bench to the bedside. J\u00a0Neurogastroenterol Motil 22:181\u2013192","journal-title":"J Neurogastroenterol Motil"},{"key":"935_CR11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1124\/jpet.115.230060","volume":"356","author":"I Tsilioni","year":"2016","unstructured":"Tsilioni I, Russell IJ, Stewart JM et al (2016) Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells. J\u00a0Pharmacol Exp Ther 356:664\u2013672","journal-title":"J Pharmacol Exp Ther"},{"key":"935_CR12","first-page":"195","volume":"32","author":"F Mastrangelo","year":"2018","unstructured":"Mastrangelo F, Frydas I, Ronconi G et al (2018) Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37. J\u00a0Biol Regul Homeost Agents 32:195\u2013198","journal-title":"J Biol Regul Homeost Agents"},{"key":"935_CR13","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1055\/s-0034-1370055","volume":"139","author":"GJ Molderings","year":"2014","unstructured":"Molderings GJ, Homann J, Brettner S et\u00a0al (2014) Systemische Mastzellaktivierungserkrankung: Ein praxisorientierter Leitfaden zu Diagnostik und Therapie. Dtsch Med Wochenschr 139:1523\u20131534","journal-title":"Dtsch Med Wochenschr"},{"key":"935_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5315\/wjh.v3.i1","volume":"3","author":"LB Afrin","year":"2014","unstructured":"Afrin LB, Molderings GJ (2014) A concise, practical guide to diagnostic assessment for mast cell activation disease. World J Hematol 3:1\u201317","journal-title":"World J Hematol"},{"key":"935_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1160\/TH11-05-0351","volume":"106","author":"H Seidel","year":"2011","unstructured":"Seidel H, Molderings GJ, Oldenburg J et\u00a0al (2011) Bleeding diathesis in patients with mast cell activation disease. Thromb Haemost 106:987\u2013989","journal-title":"Thromb Haemost"},{"key":"935_CR16","doi-asserted-by":"publisher","first-page":"e0124912","DOI":"10.1371\/journal.pone.0124912","volume":"10","author":"M Vysniauskaite","year":"2015","unstructured":"Vysniauskaite M, Hertfelder H\u2011J, Oldenburg J et al (2015) Determination of plasma heparin level improves identification of systemic mast cell activation disease. PLoS ONE 10:e124912","journal-title":"PLoS ONE"},{"key":"935_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000328760","volume":"157","author":"P Valent","year":"2012","unstructured":"Valent P, Akin C, Arock M et\u00a0al (2012) Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a\u00a0consensus proposal. Int Arch Allergy Immunol 157:215\u2013225","journal-title":"Int Arch Allergy Immunol"},{"key":"935_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.critrevonc.2014.09.001","volume":"93","author":"GJ Molderings","year":"2015","unstructured":"Molderings GJ (2015) The genetic basis of mast cell activation disease\u2014looking through a\u00a0glass darkly. Crit Rev Oncol Hematol 93:75\u201389","journal-title":"Crit Rev Oncol Hematol"},{"key":"935_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5315\/wjh.v3.i1","volume":"3","author":"LB Afrin","year":"2014","unstructured":"Afrin LB, Molderings GJ (2014) A concise, practical guide to diagnostic assessment for mast cell activation disease. World J Hematol 3:1\u201317","journal-title":"World J Hematol"},{"key":"935_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1478-811X-11-13","volume":"11","author":"OS Yousefi","year":"2013","unstructured":"Yousefi OS, Wilhelm T, Maschke-Neu\u00df K et al (2013) The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions. Cell Commun Signal 11:13","journal-title":"Cell Commun Signal"},{"key":"935_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1024\/0040-5930\/a000174","volume":"68","author":"C Henzen","year":"2011","unstructured":"Henzen C (2011) Nebennierenrindeninsuffizienz \u2013 Abkl\u00e4rung und Therapie im klinischen Alltag. Ther Umsch 68:337\u2013343","journal-title":"Ther Umsch"},{"key":"935_CR22","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/eji.201746951","volume":"47","author":"T Zhang","year":"2017","unstructured":"Zhang T, Che D, Liu R et\u00a0al (2017) Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2. Eur J Immunol 47:1949\u20131958","journal-title":"Eur J Immunol"},{"key":"935_CR23","doi-asserted-by":"publisher","first-page":"11628","DOI":"10.1038\/s41598-018-29965-8","volume":"8","author":"A Navin\u00e9s-Ferrer","year":"2018","unstructured":"Navin\u00e9s-Ferrer A, Serrano-Candelas E, Lafuente A et al (2018) MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Sci Rep 8:11628","journal-title":"Sci Rep"},{"key":"935_CR24","doi-asserted-by":"publisher","first-page":"AB35","DOI":"10.1016\/j.jaci.2017.12.113","volume":"141","author":"M Shtessel","year":"2018","unstructured":"Shtessel M et\u00a0al (2018) In vivo mast cell activation by the MRGPRX2 receptor ligands. J\u00a0Allergy Clin Immunol 141:AB35","journal-title":"J Allergy Clin Immunol"},{"key":"935_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11882-012-0269-0","volume":"12","author":"M Abajian","year":"2012","unstructured":"Abajian M, M\u0142ynek A, Maurer M (2012) Physical urticaria. Curr Allergy Asthma Rep 12:281\u2013287","journal-title":"Curr Allergy Asthma Rep"},{"key":"935_CR26","volume-title":"Never bet against Occam: Mast cell activation disease and the modern epidemics of chronic illness and medical complexity","author":"LB Afrin","year":"2016","unstructured":"Afrin LB (2016) Never bet against Occam: Mast cell activation disease and the modern epidemics of chronic illness and medical complexity. Sisters Media LLC, Bethesda"},{"key":"935_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaip.2013.09.004","volume":"2","author":"S Jennings","year":"2014","unstructured":"Jennings S, Russell N, Jennings B et\u00a0al (2014) The mastocytosis society survey on mast cell disorders: patient experiences and perceptions. J\u00a0Allergy Clin Immunol Pract 2:70\u201376","journal-title":"J Allergy Clin Immunol Pract"},{"key":"935_CR28","first-page":"517","volume":"23","author":"A Moreno-Ancillo","year":"2013","unstructured":"Moreno-Ancillo A, Gil-Adrados AC, Dom\u00ednguez-Noche C et al (2013) Bleeding and shock in a\u00a044-year-old woman with systemic mastocytosis. J\u00a0Investig Allergol Clin Immunol 23:517\u2013518","journal-title":"J Investig Allergol Clin Immunol"},{"key":"935_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/1076029607309173","volume":"14","author":"C Sucker","year":"2008","unstructured":"Sucker C, Mansmann G, Steiner S et al (2008) Fatal bleeding due to a\u00a0heparin-like anticoagulant in a\u00a037-year-old woman suffering from systemic mastocytosis. Clin Appl Thromb Hemost 14:360\u2013364","journal-title":"Clin Appl Thromb Hemost"},{"key":"935_CR30","first-page":"e629","volume":"8","author":"M Ahmed","year":"2016","unstructured":"Ahmed M, Kesavan M, Jilani BN et\u00a0al (2016) Systemic mastocytosis as an unconventional cause of variceal bleeding: think outside the box. Cureus 8:e629","journal-title":"Cureus"},{"key":"935_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1213\/00000539-198503000-00008","volume":"64","author":"JC Horrow","year":"1985","unstructured":"Horrow JC (1985) Protamine: a\u00a0review of its toxicity. Anesth Analg 64:348\u2013361","journal-title":"Anesth Analg"},{"key":"935_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejphar.2012.12.003","volume":"700","author":"K Hoffmann","year":"2013","unstructured":"Hoffmann K, Xifr\u00f3 RA, Hartweg JL et al (2013) Inhibitory effects of benzodiazepines on the adenosine A(2B) receptor mediated secretion of interleukin-8 in human mast cells. Eur J Pharmacol 700:152\u2013158","journal-title":"Eur J Pharmacol"},{"key":"935_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1478-3231.2008.01839.x","volume":"29","author":"K Alfter","year":"2009","unstructured":"Alfter K, von K\u00fcgelgen I, Haenisch B et\u00a0al (2009) New aspects of liver abnormalities as part of the systemic mast cell activation syndrome. Liver Int 29:181\u2013186","journal-title":"Liver Int"},{"key":"935_CR34","first-page":"E849","volume":"20","author":"S Wirz","year":"2017","unstructured":"Wirz S, Molderings GJ (2017) A practical guide for treatment of pain in patients with systemic mast cell activation disease. Pain Physician 20:E849\u2013E861","journal-title":"Pain Physician"},{"key":"935_CR35","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3389\/fphar.2017.00852","volume":"8","author":"X Zhou","year":"2017","unstructured":"Zhou X, Xiao Z, Xu Y et\u00a0al (2017) Electrophysiological and pharmacological analyses of Nav1.9 voltage-gated sodium channel by establishing a\u00a0heterologous expression system. Front Pharmacol 8:852","journal-title":"Front Pharmacol"},{"key":"935_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jhep.2017.07.005","volume":"67","author":"WM Lee","year":"2017","unstructured":"Lee WM (2017) Acetaminophen (APAP) hepatotoxicity\u2014Isn\u2019t it time for APAP to go away? J\u00a0Hepatol 67:1324\u20131331","journal-title":"J Hepatol"},{"key":"935_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2016.03.003","volume":"174","author":"LB Afrin","year":"2016","unstructured":"Afrin LB (2016) Mast cell disease: beyond allergy and mastocytosis. Transl Res 174:1\u20134","journal-title":"Transl Res"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-019-0935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-019-0935-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-019-0935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:37:20Z","timestamp":1584059840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-019-0935-z"}},"subtitle":["Empfehlungen f\u00fcr das perioperative Management"],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["935"],"URL":"https:\/\/doi.org\/10.1007\/s00104-019-0935-z","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]},"assertion":[{"value":"14 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Sido, J.\u00a0Homann, H.-J.\u00a0Hertfelder, T.\u00a0Zienkiewicz, K.-P.\u00a0Christians, P.\u00a0Schablin, M.\u00a0M\u00fccke und G.J.\u00a0Molderings geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}